3
3
1
1
1
1
1
1
2
2
2016
2007
Company (8)
1 - 8 of 8
Sort by
Patent
Publication NumberES 2580108 T3Filing StatusOtherAvailabilityUnknownFiling Date2006-07-11Publication Date2016-08-19
Compuesto según la fórmula (I):**Fórmula** en la que A es un isoquinolin-6-ilo sustituido o no sustituido, en la que el radical de isoquinolina puede estar mono o disustituido con halógeno, ciano, nitro o alquilo C1-C4; R1, R2, R3, R4 y R5 son, independientemente, hidrógeno, halógeno, alquilo C1-C8, alcoxilo, fenoxilo, -OR7, amino, nitro, ciano, arilo, alquilarilo C1-C4, heteroarilo, alquil C1-C4-heteroarilo, carbonilamino, tioalquilo, sulfonilo, sulfonilamino, acilo o carboxilo; R7 es alquil…
Patent
Publication NumberEP 1910297 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2006-07-11Publication Date2016-05-25
Patent
Publication NumberUS 20100093790Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2009-12-16Publication Date2010-04-15
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
Patent
Publication NumberUS 20090069371Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2008-11-20Publication Date2009-03-12
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
Patent
Publication NumberUS 7470787Filing StatusIssued PatentAvailabilityUnknownFiling Date2006-07-11Publication Date2008-12-30
Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
Patent
Publication NumberUS 20070135499Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2006-07-11Publication Date2007-06-14
Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the hydrazide compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions controlled or influenced by GPCRs are also provided. Various methods usi…
Patent
Publication NumberWO 2007008926 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2006-07-11Publication Date2007-01-18
Isoquinoline compounds are provided that influence, inhibit or reduce the action of a G-protein receptor kinase . Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.
Patent
Publication NumberWO 2007008942 A2Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2006-07-11Publication Date2007-01-18
Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the hydrazide compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions controlled or influenced by GPCRs are also provided. Various methods usi…
We found 8 documents that match your Search
Patents: 8

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in